“LL-37”的搜索结果，显示 21-30 项，共有 6960 项

1. 外科 - 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44 · Go to page 55 · NextNext Page. 以下为当前的临床试验。 131 研究外科（仅限开放性研究）. 按位置、状态和其他条件筛选 ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   Go to page 22 · Go to page 33 · Go to page 44 · NextNext Page. 以下为当前的临床试验。 37 研究肾病和高血压（仅限开放性研究）. 按位置、状态和其他条件筛选该研究 ...

3. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

5. 神经科- 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

6. 血管中心- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop a Registry of participants with MacTel Type 2 (as confirmed by the Reading Center) who may agree to be contacted for ...

7. 血液科- 临床试验- 妙佑医疗国际

   ... 2). In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be ...

8. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   This phase II trial compares the impact of subcutaneous (SC) nivolumab ... 2. Unwilling to participate or unable to consent. 3. Known liver disease ...

9. 血液科- 临床试验- 妙佑医疗国际

   This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

10. 神经科- 临床试验- 妙佑医疗国际

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...